Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Principal Investigator
Name
Lois Lamerato
Institution
Henry Ford Health System
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
2006-0162
Initial CDAS Request Approval
Jul 1, 2006
Title
Who Participates in Clinical Trials
Summary
Recruitment of healthy subjects to long-term randomized controlled trials (RCTs) of cancer prevention or early detection has proven to be a difficult task. To quantify recruitment yield as well as characteristics of successfully recruited participants, we examined recruitment outcomes at HFHS. Data were obtained from administrative databases from HFHS and from PLCO study databases
Aims

To examine factors that affect recruitment within HFHS for the PLCO trial.

Collaborators

Christine Cole Johnson (Henry Ford Health System)
G. Jacobsen
Pam Marcus (Division of Cancer Prevention)

Related Publications